APLT — Applied Therapeutics Balance Sheet
0.000.00%
- $56.45m
- -$22.95m
- $0.46m
- 14
- 15
- 44
- 13
Annual balance sheet for Applied Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 96.8 | 80.8 | 30.6 | 50.2 | 79.4 |
Prepaid Expenses | |||||
Total Current Assets | 103 | 88.4 | 37.3 | 54.4 | 83.6 |
Net Property, Plant And Equipment | 1.71 | 1.3 | 0.857 | 0.447 | 2.79 |
Other Long Term Assets | |||||
Total Assets | 105 | 89.9 | 38.4 | 54.8 | 86.7 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 21.2 | 26.5 | 33.4 | 71.2 | 27.3 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 22.6 | 27.4 | 34.3 | 72 | 29.7 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 81.9 | 62.5 | 4.06 | -17.1 | 57 |
Total Liabilities & Shareholders' Equity | 105 | 89.9 | 38.4 | 54.8 | 86.7 |
Total Common Shares Outstanding |